# COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and Methamphetamine Dependence Treatment Response: Preliminary Investigation

## Metadata
**Authors:** Keith G Heinzerling, James T McCracken, Aimee-Noelle Swanson, Lara A Ray, Steven J Shoptaw
**Journal:** Journal of clinical psychopharmacology
**Date:** 2012 Feb
**DOI:** [10.1097/JCP.0b013e318240a48e](https://doi.org/10.1097/JCP.0b013e318240a48e)
**PMID:** 22217949
**PMCID:** PMC3597465
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597465/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC3597465/pdf/nihms358499.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC3597465/pdf/nihms358499.pdf)

## Acknowledgments

**Funding and Support:** Funding for this study was provided by NIDA Grants 1 K23 DA 023558 (Heinzerling) and 1 P50 DA 18185 (Shoptaw). Study medication and matching placebo was provided by Cephalon, Inc.; Cephalon had no further role in the study. The authors have no conflicts of interest to report.

## References

1. Heinzerling KG, Swanson AN, Kim S, et al. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2010;109(1-3):20–9. doi: 10.1016/j.drugalcdep.2009.11.023.  [DOI](https://doi.org/10.1016/j.drugalcdep.2009.11.023) | [PMC free article](/articles/PMC2875545/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/20092966/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Drug%20Alcohol%20Depend&title=Randomized,%20double-blind,%20placebo-controlled%20trial%20of%20modafinil%20for%20the%20treatment%20of%20methamphetamine%20dependence&author=KG%20Heinzerling&author=AN%20Swanson&author=S%20Kim&volume=109&issue=1-3&publication_year=2010&pages=20-9&pmid=20092966&doi=10.1016/j.drugalcdep.2009.11.023&)

2. Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112(2):257–69. doi: 10.1016/s0092-8674(03)00035-7.  [DOI](https://doi.org/10.1016/s0092-8674(03)00035-7) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/12553913/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell&title=The%20BDNF%20val66met%20polymorphism%20affects%20activity-dependent%20secretion%20of%20BDNF%20and%20human%20memory%20and%20hippocampal%20function&author=MF%20Egan&author=M%20Kojima&author=JH%20Callicott&volume=112&issue=2&publication_year=2003&pages=257-69&pmid=12553913&doi=10.1016/s0092-8674(03)00035-7&)

3. Flanagin BA, Cook EH., Jr de Wit H. An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(6):576–83. doi: 10.1002/ajmg.b.30327.  [DOI](https://doi.org/10.1002/ajmg.b.30327) | [PMC free article](/articles/PMC2556402/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/16823800/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am%20J%20Med%20Genet%20B%20Neuropsychiatr%20Genet&title=de%20Wit%20H.%20An%20association%20study%20of%20the%20brain-derived%20neurotrophic%20factor%20Val66Met%20polymorphism%20and%20amphetamine%20response&author=BA%20Flanagin&author=EH%20Cook&volume=141B&issue=6&publication_year=2006&pages=576-83&pmid=16823800&doi=10.1002/ajmg.b.30327&)

4. Lachman HM, Papolos DF, Saito T, et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6(3):243–50. doi: 10.1097/00008571-199606000-00007.  [DOI](https://doi.org/10.1097/00008571-199606000-00007) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/8807664/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pharmacogenetics&title=Human%20catechol-O-methyltransferase%20pharmacogenetics:%20description%20of%20a%20functional%20polymorphism%20and%20its%20potential%20application%20to%20neuropsychiatric%20disorders&author=HM%20Lachman&author=DF%20Papolos&author=T%20Saito&volume=6&issue=3&publication_year=1996&pages=243-50&pmid=8807664&doi=10.1097/00008571-199606000-00007&)

5. Hamidovic A, Dlugos A, Palmer AA, et al. Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatr Genet. 2010;20(3):85–92. doi: 10.1097/YPG.0b013e32833a1f3c.  [DOI](https://doi.org/10.1097/YPG.0b013e32833a1f3c) | [PMC free article](/articles/PMC2875066/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/20414144/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Psychiatr%20Genet&title=Catechol-O-methyltransferase%20val158met%20genotype%20modulates%20sustained%20attention%20in%20both%20the%20drug-free%20state%20and%20in%20response%20to%20amphetamine&author=A%20Hamidovic&author=A%20Dlugos&author=AA%20Palmer&volume=20&issue=3&publication_year=2010&pages=85-92&pmid=20414144&doi=10.1097/YPG.0b013e32833a1f3c&)

6. Mague SD, Blendy JA. OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend. 2010;108(3):172–82. doi: 10.1016/j.drugalcdep.2009.12.016.  [DOI](https://doi.org/10.1016/j.drugalcdep.2009.12.016) | [PMC free article](/articles/PMC2887703/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/20074870/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Drug%20Alcohol%20Depend&title=OPRM1%20SNP%20(A118G):%20involvement%20in%20disease%20development,%20treatment%20response,%20and%20animal%20models&author=SD%20Mague&author=JA%20Blendy&volume=108&issue=3&publication_year=2010&pages=172-82&pmid=20074870&doi=10.1016/j.drugalcdep.2009.12.016&)

7. Dlugos AM, Hamidovic A, Hodgkinson C, et al. OPRM1 gene variants modulate amphetamine-induced euphoria in humans. Genes Brain Behav. 2010 doi: 10.1111/j.1601-183X.2010.00655.x.  [DOI](https://doi.org/10.1111/j.1601-183X.2010.00655.x) | [PMC free article](/articles/PMC3377371/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/21029375/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Genes%20Brain%20Behav&title=OPRM1%20gene%20variants%20modulate%20amphetamine-induced%20euphoria%20in%20humans&author=AM%20Dlugos&author=A%20Hamidovic&author=C%20Hodgkinson&publication_year=2010&pmid=21029375&doi=10.1111/j.1601-183X.2010.00655.x&)

8. Bodenmann S, Xu S, Luhmann UFO, et al. Pharmacogenetics of Modafinil After Sleep Loss: Catechol-O-Methyltransferase Genotype Modulates Waking Functions But Not Recovery Sleep. Clinical Pharmacology & Therapeutics. 2009;85(3):296–304. doi: 10.1038/clpt.2008.222.  [DOI](https://doi.org/10.1038/clpt.2008.222) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/19037200/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clinical%20Pharmacology%20&%20Therapeutics&title=Pharmacogenetics%20of%20Modafinil%20After%20Sleep%20Loss:%20Catechol-O-Methyltransferase%20Genotype%20Modulates%20Waking%20Functions%20But%20Not%20Recovery%20Sleep&author=S%20Bodenmann&author=S%20Xu&author=UFO%20Luhmann&volume=85&issue=3&publication_year=2009&pages=296-304&pmid=19037200&doi=10.1038/clpt.2008.222&)
